Equity Snap: IQVIA Holding Inc (IQV US): Beat and raise; strong organic revenue growth and btb numbers

Research evidence excerpt

Equity Snap: IQVIA Holding Inc (IQV US): Beat and raise; strong organic revenue growth and btb numbers

28 July 2026

Equity Snap: IQVIA Holding Inc Equities Health Care Providers &

(IQV US) Srvcs

Beat and raise; strong organic revenue growth and

btb numbers United States

◆ Q2 was a beat, driven primarily by R&D Solutions; FY26 Shubhangi Gupta*, PhD

guidance raised GlobalHSBC SecuritiesLife Sciencesand Capital& HealthcareMarketsAnalyst(India) Private

Limited

◆ Strong organic revenue growth and b-t-b vs consensus shubhangi.gupta@hsbc.co.in

+91 80 4555 2143

Rajesh Kumar*

IQVIA Holding Inc (IQV US, USD208.05, Buy, TP USD240.00) Senior Global Life Sciences & Healthcare Analyst

(Priced as of 24 Jul 2026) HSBC Bank plc

rajesh4kumar@hsbcib.com

FY26 outlook upgraded: IQVIA has updated its FY26 outlook which is c1% ahead of the +44 20 7991 1629

previous outlook on revenue, adj EBITDA, and adj EPS. The outlook is c1% ahead of Morten Herholdt*

Global Life Sciences & Healthcare Analyst

consensus expectations on top- and bottom-line. The new mid-point of the revenue HSBC Bank plc

growth guidance is 6.5% versus the prior guidance of 5.8%, reflecting approximately 100 morten.herholdt@hsbc.com + 44 20 7992 4082

basis points higher organic revenue growth, and approximately 50 basis points higher

contribution from M&A offset by approximately 80 basis points unfavourable change in * Employed by a non-US affiliate of HSBC Securities (USA) Inc, and is

foreign exchange impact, all versus prior guidance. VA cons is at the upper-end of adj not registered/ qualified pursuant to FINRA regulations

EPS guidance for H2 26.

Q2 beat: Q2 revenues were +1.5% ahead of consensus with Research and Development

Solutions (R&D Solutions) 2.5% ahead. Revenue growth at cc was 222bps ahead of

consensus.